Navigation Links
Study sheds light on late phase of asthma attacks
Date:8/12/2011

New research led by scientists from Imperial College London explains why around half of people with asthma experience a 'late phase' of symptoms several hours after exposure to allergens. The findings, published in the journal Thorax, could lead to better treatments for the disease.

An estimated 300 million people suffer from asthma, and the prevalence is rising. Symptoms are commonly triggered by allergens in the environment, such as pollen and dust mites. These stimuli can cause the airways to tighten within minutes, causing breathing difficulties which range from mild to severe. Many sufferers also experience a 'late asthmatic response' three to eight hours after exposure to allergens, causing breathing difficulties which can last up to 24 hours.

In the early asthmatic response, the allergen is recognised by mast cells, which release chemical signals that cause the airways to narrow. In contrast, the mechanism behind the late phase has remained unclear.

In research on mice and rats, the Imperial team have now found evidence that the late asthmatic response happens because the allergen triggers sensory nerves in the airways. These nerves activate reflexes which trigger other nerves that release the neurotransmitter acetylcholine, which causes the airways to narrow. If the findings translate to humans, it would mean that drugs that block acetylcholine called anticholinergics could be used to treat asthma patients that experience late phase responses following exposure to allergens.

Steroids are the main treatments for asthma prescribed now, but they are not effective for all patients. A recent clinical trial involving 210 asthma patients found that the anticholinergic drug tiotropium improved symptoms when added to a steroid inhaler, but the reason for this was unexplained.

"Many asthmatics have symptoms at night after exposure to allergens during the day, but until now we haven't understood how this la
'/>"/>

Contact: Sam Wong
sam.wong@imperial.ac.uk
44-207-594-2198
Imperial College London
Source:Eurekalert

Page: 1 2

Related biology news :

1. BUSM professor awarded $13.3 million to study potential treatments to prevent STDs
2. Decade-long study reveals recurring patterns of viruses in the open ocean
3. Study builds on plausible scenario for origin of life on Earth
4. Penn study shows an ancient crop effective in protecting against a 21st century hazard
5. Finding their way: Study shows connection between academic direction and student learning
6. Study: Severe low temperatures devastate coral reefs in Florida Keys
7. UGA researchers study threats to white sturgeon
8. UCLA study shows man-made fat may limit damage to heart attack victims
9. Montana State University team surprised by results of lung, mold study
10. UCLA life scientists study of abalone yields new insights into sexual reproduction
11. USDA scientists study effects of rising carbon dioxide on rangelands
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... July 24, 2014 -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the ... randomized, active control Phase 3 study of Zerenex (ferric ... for the treatment of hyperphosphatemia in patients with end-stage ... binding and iRon delivery with FErric CiTrate in EsrD) ... the American Society of Nephrology ( JASN ). ...
(Date:7/24/2014)... (July 24, 2014) Scientists at The New ... one step closer to creating a viable cell ... own cells. , For the first time, ... lines from skin samples of patients with primary ... accelerated protocol to induce these stem cells into ...
(Date:7/24/2014)... over a 35 year period in which the human ... humans on declining animal numbers. This decline matters because ... crustaceans, slugs and worms bring to our day-to-day lives, ... nutrient cycling, water filtration and human health. , The ... UCL, Stanford and UCSB, focused on the demise of ...
Breaking Biology News(10 mins):Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4NYSCF scientists 1 step closer to cell therapy for multiple sclerosis patients 2Invertebrate numbers nearly halve as human population doubles 2Invertebrate numbers nearly halve as human population doubles 3
... of seven tropical forests around the world has revealed ... less common trees. The landmark study, conducted by 33 ... 27 issue of the journal Science, conclusively demonstrates that ... , Helene Muller-Landau, an assistant professor of ecology in ...
... Mellon University have discovered that our ears use the ... from babbling brooks to wailing babies. These results represent ... is encoded for transmission to the brain, according to ... "News and Views" editorial in the Feb. 23 issue ...
... of Pittsburgh Professor of Anthropology Jeffrey H. Schwartz and ... Jan. 30 in the New Anatomist journal, shows that ... to Schwartz's theory of evolution, originally explained in his ... of Species (John Wiley & Sons, 2000). , In ...
Cached Biology News:Underdogs in the understory: Study suggests nature favors rarer trees 2Carnegie Mellon scientists show brain uses optimal code for sound 2Carnegie Mellon scientists show brain uses optimal code for sound 3Pitt professor's theory of evolution gets boost from cell research 2Pitt professor's theory of evolution gets boost from cell research 3
(Date:7/24/2014)... (PRWEB) July 24, 2014 The ... of molecular diagnostic test results. It also enables ... for the validation and reporting of high profile ... diagnostics is a rapidly growing area of biotechnology ... genetic predisposition, cancer, and companion diagnostics in personalized ...
(Date:7/23/2014)... 23, 2014  Sangamo BioSciences, Inc. (NASDAQ: ... results and accomplishments. For the second ... net loss of $7.0 million, or $0.10 per share, ... $0.10 per share, for the same period in 2013. ... cash equivalents, marketable securities and interest receivable of $236.7 ...
(Date:7/23/2014)... the Helmholtz-Zentrum Dresden-Rossendorf (HZDR), the Vienna University of ... succeeded in embedding nearly perfect semiconductor crystals into ... producing hybrid nanowires, very fast and multi-functional processing ... in the future. The research results will be ... , Nano-optoelectronics are considered the cornerstone of future ...
(Date:7/23/2014)... 23, 2014 Shimadzu Scientific Instruments ... acid analysis system developed jointly with Ajinomoto Co. ... can analyze 38 amino acids in nine minutes, ... achieves high-speed analysis utilizing a fast application-specific column ... accurate analytical results even under conditions with difficult ...
Breaking Biology Technology:New DNA-barcode Patent Virtually Eliminates False Test Results and Sample Mix-up 2Sangamo BioSciences Reports Second Quarter 2014 Financial Results 2Sangamo BioSciences Reports Second Quarter 2014 Financial Results 3Sangamo BioSciences Reports Second Quarter 2014 Financial Results 4Sangamo BioSciences Reports Second Quarter 2014 Financial Results 5Sangamo BioSciences Reports Second Quarter 2014 Financial Results 6Sangamo BioSciences Reports Second Quarter 2014 Financial Results 7Sangamo BioSciences Reports Second Quarter 2014 Financial Results 8Sangamo BioSciences Reports Second Quarter 2014 Financial Results 9A crystal wedding in the nanocosmos 2Shimadzu's New UF-Amino Station Provides High-Speed, Multi-Component Analysis of Amino Acids in Food & Beverage and Pharmaceutical Testing 2
... Medarex, Inc.,(Nasdaq: MEDX ) announced today that it ... Conference at 10:30 a.m. ET on Tuesday, January,8, 2008. ... available in the,Investor Relations section of the Medarex Web ... presentation will be available following the event., About ...
... PARK, N.C., Jan. 3 Chimerix, Inc., a,biotechnology ... Neil Frazer, M.B., Ch.B., FRCA, FFPM has joined ... joining Chimerix, Dr. Frazer served as the Chief ... (previously,Biocure Medical) where he was responsible for the ...
... (Nasdaq: ONXX ) today announced that it ... January 7, at 11:30 a.m.,Pacific Time. Interested parties ... http://www.metameetings.com/webcasts/jpmorgan/healthcare08 , It is recommended ... order to,register and download any necessary software. For ...
Cached Biology Technology:Chimerix Appoints Neil Frazer, M.B., Ch.B., FRCA, FFPM as Chief Medical Officer 2
ID clarifier: platform...
The PROTEAN II xi multi-cell 2-D conversion kit converts the PROTEAN II xi multi-cell to the PROTEAN II XL multi-cell for a wider format cell that accepts 17 to 18 cm IPG strips....
The SVT3-2 diverter valve is a 3-port, 2-position valve for use with the BioLogic DuoFlow system....
... is used for vertical electrophoresis applications. The cell accommodates ... L of running buffer. It includes the PROTEAN II ... kit, which contains accessories for use with 2.0 mm ... 2 sets of 20 x 20 cm glass plates, ...
Biology Products: